Cytokine secretion from brain macrophages infected with human immunodeficiency virus in vitro and treated with raltegravir

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Tatro, Erick T ^a   Soontornniyomkij, Benchawanna ^a   Letendre, Scott L ^b   Achim, Cristian L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Human immunodeficiency virus; IL 10; IL 8; Integrase inhibitor; Microglia; Raltegravir; TNF

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; RALTEGRAVIR; TUMOR NECROSIS FACTOR ALPHA; 2 PYRROLIDONE DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; ASTROCYTOSIS; BRAIN MACROPHAGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; FEMALE; GLIAL CELL CULTURE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; LIMIT OF DETECTION; MACROPHAGE; MICROGLIA; NERVE GROWTH; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; SUPERNATANT; TISSUE CULTURE; VIRUS CELL INTERACTION; BRAIN; DRUG EFFECTS; EMBRYOLOGY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; SECRETION (PROCESS); VIROLOGY;

BRAIN; CYTOKINES; HIV INFECTIONS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-6; INTERLEUKIN-8; MACROPHAGES; MICROGLIA; PYRROLIDINONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84904074007     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-386     Document Type: Article

References (31)

1. Gabuzda DH, Ho DD, de la Monte SM, Hirsch MS, Rota TR, Sobel RA. Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann Neurol 1986, 20(3):289-295. 10.1002/ana.410200304, 3532930.
2. Kure K, Weidenheim KM, Lyman WD, Dickson DW. Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration. Acta Neuropathol 1990, 80(4):393-400. 10.1007/BF00307693, 2239151.
3. Lackner AA, Smith MO, Munn RJ, Martfeld DJ, Gardner MB, Marx PA, Dandekar S. Localization of simian immunodeficiency virus in the central nervous system of rhesus monkeys. Am J Pathol 1991, 139(3):609-621. 1886212, 1716047.
4. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A 1986, 83(18):7089-7093. 10.1073/pnas.83.18.7089, 386658, 3018755.
5. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373(6510):123-126. 10.1038/373123a0, 7816094.
6. Lambotte O, Deiva K, Tardieu M. HIV-1 persistence, viral reservoir, and the central nervous system in the HAART era. Brain Pathol 2003, 13(1):95-103.
7. Lassmann H, Schmied M, Vass K, Hickey WF. Bone marrow derived elements and resident microglia in brain inflammation. Glia 1993, 7(1):19-24. 10.1002/glia.440070106, 7678581.
8. Wiley CA. Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection. Brain Pathol 2003, 13(3):415. author reply 415-416.
9. Bissel SJ, Wang G, Ghosh M, Reinhart TA, Capuano S, Stefano Cole K, Murphey-Corb M, Piatak M, Lifson JD, Wiley CA. Macrophages relate presynaptic and postsynaptic damage in simian immunodeficiency virus encephalitis. Am J Pathol 2002, 160(3):927-941. 10.1016/S0002-9440(10)64915-2, 3278766, 11891191.
10. Boasso A, Shearer GM. Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. Clin Immunol 2008, 126(3):235-242. 10.1016/j.clim.2007.08.015, 2275778, 17916442.
11. Garvey LJ, Pavese N, Politis M, Ramlackhansingh A, Brooks DJ, Taylor-Robinson SD, Winston A. Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART. Aids 2014, 28(1):67-72. 10.1097/01.aids.0000432467.54003.f7, 23887068.
12. Kaul M, Zheng J, Okamoto S, Gendelman HE, Lipton SA. HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ 2005, 12(Suppl 1):878-892.
13. Robertson K, Liner J, Meeker RB. Antiretroviral neurotoxicity. J Neurovirol 2012, 18(5):388-399. 10.1007/s13365-012-0120-3, 3581315, 22811264.
14. Markowitz M, Nguyen BY, Gotuzzo E, Mendo F, Ratanasuwan W, Kovacs C, Prada G, Morales-Ramirez JO, Crumpacker CS, Isaacs RD, Gilde LR, Wan H, Miller MD, Wenning LA, Teppler H, . Protocol 004 Part II Study Team Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study. J Acquir Immune Defic Syndr 2007, 46(2):125-133. 10.1097/QAI.0b013e318157131c, 17721395, Protocol 004 Part II Study Team.
15. Hazuda DJ, Felock P, Witmer M, Wolfe A, Stillmock K, Grobler JA, Espeseth A, Gabryelski L, Schleif W, Blau C, Miller MD. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science 2000, 287(5453):646-650. 10.1126/science.287.5453.646, 10649997.
16. Cooper A, Garcia M, Petrovas C, Yamamoto T, Koup RA, Nabel GJ. HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration. Nature 2013, 498(7454):376-379. 10.1038/nature12274, 23739328.
17. Albright AV, Shieh JT, O'Connor MJ, Gonzalez-Scarano F. Characterization of cultured microglia that can be infected by HIV-1. J Neurovirol 2000, 6(Suppl 1):S53-S60.
18. Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 1986, 233(4760):215-219. 10.1126/science.3014648, 3014648.
19. White MG, Hammond RR, Sanders VJ, Bonaroti EA, Mehta AP, Wang G, Wiley CA, Achim CL. Neuron-enriched second trimester human cultures: growth factor response and in vivo graft survival. Cell Transplant 1999, 8(1):59-73.
20. Nguyen TB, Lucero GR, Chana G, Hult BJ, Tatro ET, Masliah E, Grant I, Achim CL, Everall IP, Group HIVNR. Glycogen synthase kinase-3beta (GSK-3beta) inhibitors AR-A014418 and B6B3O prevent human immunodeficiency virus-mediated neurotoxicity in primary human neurons. J Neurovirol 2009, 15(5-6):434-438. 3065998, 19688630.
21. Tatro ET, Everall IP, Kaul M, Achim CL. Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder. Brain Res 2009, 1286:1-12. 2724600, 19545546.
22. Eron JJ, Rockstroh JK, Reynes J, Andrade-Villanueva J, Ramalho-Madruga JV, Bekker LG, Young B, Katlama C, Gatell-Artigas JM, Arribas JR, Nelson M, Campbell H, Zhao J, Rodgers AJ, Rizk ML, Wenning L, Miller MD, Hazuda D, DiNubile MJ, Leavitt R, Isaacs R, Robertson MN, Sklar P, Nguyen BY, . QDMRK Investigators Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial. Lancet Infect Dis 2011, 11(12):907-915. 10.1016/S1473-3099(11)70196-7, 21933752, QDMRK Investigators.
23. Croteau D, Letendre S, Best BM, Ellis RJ, Breidinger S, Clifford D, Collier A, Gelman B, Marra C, Mbeo G, McCutchan A, Morgello S, Simpson D, Way L, Vaida F, Ueland S, Capparelli E, Grant I, . CHARTER Group Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1. Antimicrob Agents Chemother 2010, 54(12):5156-5160. 10.1128/AAC.00507-10, 2981289, 20876368, CHARTER Group.
24. Molto J, Valle M, Back D, Cedeno S, Watson V, Liptrott N, Egan D, Miranda C, Barbanoj MJ, Clotet B. Plasma and intracellular (peripheral blood mononuclear cells) pharmacokinetics of once-daily raltegravir (800 milligrams) in HIV-infected patients. Antimicrob Agents Chemother 2011, 55(1):72-75. 10.1128/AAC.00789-10, 3019627, 20937791.
25. Everall IP, Hansen LA, Masliah E. The shifting patterns of HIV encephalitis neuropathology. Neurotox Res 2005, 8(1-2):51-61.
26. Kim BO, Liu Y, Ruan Y, Xu ZC, Schantz L, He JJ. Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline. Am J Pathol 2003, 162(5):1693-1707. 10.1016/S0002-9440(10)64304-0, 1851199, 12707054.
27. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989, 84(4):1045-1049. 10.1172/JCI114265, 329758, 2677047.
28. Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MA, Luster AD, Luscinskas FW, Rosenzweig A. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999, 398(6729):718-723. 10.1038/19546, 10227295.
29. Denis M, Ghadirian E. Dysregulation of interleukin 8, interleukin 10, and interleukin 12 release by alveolar macrophages from HIV type 1-infected subjects. AIDS Res Hum Retroviruses 1994, 10(12):1619-1627. 10.1089/aid.1994.10.1619, 7888221.
30. Zheng JC, Huang Y, Tang K, Cui M, Niemann D, Lopez A, Morgello S, Chen S. HIV-1-infected and/or immune-activated macrophages regulate astrocyte CXCL8 production through IL-1beta and TNF-alpha: involvement of mitogen-activated protein kinases and protein kinase R. J Neuroimmunol 2008, 200(1-2):100-110. 2596956, 18653246.
31. Melchjorsen J, Risor MW, Sogaard OS, O'Loughlin KL, Chow S, Paludan SR, Ellermann-Eriksen S, Hedley DW, Minderman H, Ostergaard L, Tolstrup M. Tenofovir selectively regulates production of inflammatory cytokines and shifts the IL-12/IL-10 balance in human primary cells. J Acquir Immune Defic Syndr 2011, 57(4):265-275. 10.1097/QAI.0b013e3182185276, 21471820.